Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP12 | P39900 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | G6PD | P11413 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.42 |
| ▸ | CASP1 | P29466 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | ANPEP | P15144 | 2/20 | 0.41 |
| ▸ | ERAP1 | Q9NZ08 | 2/20 | 0.41 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.41 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.41 |
| ▸ | HTR2A | P28223 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29085624 | 0.88 | MMP12 (0.41) | MMP12TSHRG6PDALDH1A1POLB | |
| SCHEMBL8071187 | 0.87 | IDO1 (0.45) | — | |
| SCHEMBL8063607 | 0.85 | L3MBTL1 (0.47) | — | |
| SCHEMBL28686580 | 0.84 | BCHE (0.61) | MMP12 | |
| SCHEMBL1977575 | 0.82 | KMT2A (0.45) | MMP12TSHRG6PDALDH1A1POLB | |
| SCHEMBL13074081 | 0.82 | MMP12 (0.57) | MMP12TSHRG6PDALDH1A1HPGD | |
| SCHEMBL29626913 | 0.82 | MMP12 (0.37) | MMP12TSHRG6PDPOLBSMN1; SMN2 | |
| SCHEMBL1781296 | 0.80 | LPL (0.47) | MMP12SMN1; SMN2 | |
| SCHEMBL13626178 | 0.80 | TSHR (0.46) | MMP12TSHRG6PDALDH1A1HPGD | |
| SCHEMBL820953 | 0.80 | TSHR (0.46) | MMP12TSHRG6PDALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150182656-A1 | Perfume Compositions | GIVAUDAN S.A. (CH) | 2015-07-02 | — | — | US | claimed |
| US-20150079017-A1 | Perfume Compositions | GIVAUDAN S.A. (CH) | 2015-03-19 | — | — | US | claimed |
| US-8821847-B2 | Perfume compositions | GIVAUDAN NEDERLAND SERVICES B.V. (NL) | 2014-09-02 | — | — | US | claimed |
| US-20130230479-A1 | Perfume Compositions | GIVAUDAN NEDERLAND SERVICES B.V. (NL) | 2013-09-05 | — | — | US | claimed |
| US-20130039876-A1 | Perfume Compositions | GIVAUDAN NEDERLAND SERVICES B.V. (NL) | 2013-02-14 | — | — | US | claimed |
| US-20130039877-A1 | Perfume Compositions | GIVAUDAN NEDERLAND SERVICES B.V. (NL) | 2013-02-14 | — | — | US | claimed |
| EP-2049638-B1 | PERFUME COMPOSITIONS | GIVAUDAN NEDERLAND SERVICES BV (NL) | 2012-10-03 | — | — | EP | claimed |
| EP-2049637-B1 | PERFUME COMPOSITIONS | GIVAUDAN NEDERLAND SERVICES BV (NL) | 2012-05-30 | — | — | EP | claimed |
| US-20090263344-A1 | Perfume Compositions | GIVAUDAN NEDERLAND SERVICES B.V. (NL) | 2009-10-22 | — | — | US | claimed |
| US-20090257974-A1 | Perfume Compositions | GIVAUDAN NEDERLAND SERVICES B.V. (NL) | 2009-10-15 | — | — | US | claimed |
| EP-2049637-A1 | PERFUME COMPOSITIONS | Givaudan Nederland Services B.V. (NL) | 2009-04-22 | — | — | EP | claimed |
| EP-2049638-A1 | PERFUME COMPOSITIONS | Givaudan Nederland Services B.V. (NL) | 2009-04-22 | — | — | EP | claimed |
| WO-2008023142-A1 | PERFUME COMPOSITIONS | GIVAUDAN NEDERLAND SERVICES B.V. (NL) | 2008-02-28 | — | — | WO | claimed |
| WO-2008017820-A1 | PERFUME COMPOSITIONS | GIVAUDAN NEDERLAND SERVICES B.V. (NL) | 2008-02-14 | — | — | WO | claimed |
| CN-119822945-A | Hyacinth fragrance compound, preparation method thereof and hyacinth fragrance type fragrance base | 波顿香料股份有限公司 | 2025-04-15 | — | — | CN | disclosed |
| CN-117203313-A | 2, 4-dimethyloctan-2, 7-dien-4-ol as perfume | 西姆莱斯股份公司 | 2023-12-08 | — | — | CN | disclosed |
| US-11773092-B1 | Pyrido[3,4-b]indol-1-one compounds as antibacterial agents | King Faisal University (SA) | 2023-10-03 | — | — | US | disclosed |
| EP-0664780-A1 | 10-SUBSTITUTED 1,8-DIHYDROXY-9(10H) ANTHRACENONE PHARMACEUTICALS | TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) | 1995-08-02 | — | — | EP | disclosed |
| US-5426197-A | Antiinflammatory, antiallergy or antitumor agents | TEVA PHARMACEUTICAL INDUSTRIES, LTD. (IL) | 1995-06-20 | — | — | US | disclosed |
| WO-1995003266-A1 | 10-SUBSTITUTED 1,8-DIHYDROXY-9(10H) ANTHRACENONE PHARMACEUTICALS | TEVA PHARMACEUTICAL INDUSTRIES, LTD. (IL) | 1995-02-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11773092-B1 | Pyrido[3,4-b]indol-1-one compounds as antibacterial agents | IDO1, IDO2, IMPA1 | MMP12 1630/4885TSHR 2244/4885G6PD 265/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.